Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS
2007

HIV-1 Envelope Variants and Their Role in Disease Progression

Sample size: 37 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jasminka Sterjovski, Melissa J Churchill, Anne Ellett, Lachlan R Gray, Michael J Roche, Rebecca L Dunfee, Damian FJ Purcell, Nitin Saksena, Bin Wang, Secondo Sonza, Steven L Wesselingh, Ingrid Karlsson, Eva-Maria Fenyo, Dana Gabuzda, Anthony L Cunningham, Paul R Gorry

Primary Institution: Macfarlane Burnet Institute for Medical Research & Public Health, Melbourne, Victoria, Australia

Hypothesis

The study investigates the role of Asn 362 in enhancing the fusogenicity of CCR5-restricted HIV-1 envelope glycoprotein variants from AIDS patients.

Conclusion

The presence of Asn 362 in HIV-1 envelope variants is associated with enhanced fusogenicity and may contribute to CD4+ T-cell loss in AIDS patients.

Supporting Evidence

  • A-R5 Envs had enhanced fusogenicity compared to PA-R5 Envs.
  • N362 was associated with faster entry kinetics of HIV-1.
  • A-R5 Envs showed reduced sensitivity to the fusion inhibitor T-20.
  • Mutagenesis studies confirmed N362's role in enhancing fusogenicity.
  • Structural models suggest N362 stabilizes the CD4-bound Env structure.
  • Presence of N362 correlated with increased sensitivity to neutralization by specific antibodies.
  • Enhanced fusogenicity may contribute to CD4+ T-cell loss in AIDS patients.

Takeaway

Some HIV-1 viruses can fuse better with human cells, which might help them make people sick faster. A specific part of the virus, called Asn 362, helps it do this.

Methodology

The study characterized 37 full-length R5 Envs from HIV-1 variants isolated from patients, using quantitative cell-cell fusion assays and sequence analysis.

Potential Biases

Potential bias in sample selection from specific patient populations.

Limitations

The study may not account for all genetic variations in HIV-1 and their effects on fusogenicity.

Participant Demographics

Patients with asymptomatic HIV-1 infection and AIDS.

Statistical Information

P-Value

0.0004

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-4690-4-89

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication